Abstract:Since it was first recognized in bacteria and archaea as a mechanism for innate viral immunity in the early 2010s, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) has rapidly been developed into a robust, multifunctional genome editing tool with many uses. Following the discovery of the initial CRISPR/Cas-based system, the technology has been advanced to facilitate a multitude of different functions. These include development as a base editor, prime editor, epigenetic editor, and CRISPR interference (CRISPRi) and CRISPR activator (CRISPRa) gene regulators. It can also be used for chromatin and RNA targeting and imaging. Its applications have proved revolutionary across numerous biological fields, especially in biomedical and agricultural improvement. As a diagnostic tool, CRISPR has been developed to aid the detection and screening of both human and plant diseases, and has even been applied during the current coronavirus disease 2019 (COVID-19) pandemic. CRISPR/Cas is also being trialed as a new form of gene therapy for treating various human diseases, including cancers, and has aided drug development. In terms of agricultural breeding, precise targeting of biological pathways via CRISPR/Cas has been key to regulating molecular biosynthesis and allowing modification of proteins, starch, oil, and other functional components for crop improvement. Adding to this, CRISPR/Cas has been shown capable of significantly enhancing both plant tolerance to environmental stresses and overall crop yield via the targeting of various agronomically important gene regulators. Looking to the future, increasing the efficiency and precision of CRISPR/Cas delivery systems and limiting off-target activity are two major challenges for wider application of the technology. This review provides an in-depth overview of current CRISPR development, including the advantages and disadvantages of the technology, recent applications, and future considerations.

The realization of CRISPR gene therapy

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

Advances in CRISPR/Cas systems-based cell and gene therapy

CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy

CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

Recent Therapeutic Gene Editing Applications to Genetic Disorders

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

CRISPR and Gene Editing: A Game-Changer in Drug Development

CRISPR-Cas9 gene editing technology in human gene therapy: the new realm of medicine

CRISPR genome-editing grows up: advanced therapies head for the clinic

Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

RNA in Therapeutics: CRISPR in the Clinic

Applications of CRISPR technologies to the development of gene and cell therapy

Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease

Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation

Therapeutic applications of CRISPR/Cas9 system in gene therapy

CRISPR/Cas9 therapeutics: progress and prospects

CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement

Delivery of CRISPR/Cas9 by novel strategies for gene therapy.